
Medicine and Health
Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease
K. Hufnagel, A. Fathi, et al.
This groundbreaking study by Katrin Hufnagel and her team uncovers plasma protein biomarkers that could forecast the progression of COVID-19 to severe illness during its early stages. Through innovative antibody microarrays and machine learning, they identified multi-marker panels that hold promise for timely patient interventions.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.